Meeting to be held in Texas on January 26 hosted by Truist.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on CHRS:
- Coherus Biosciences management to meet with Truist
- Coherus agrees to acquire exclusive U.S. commercial rights to FYB203
- Coherus Agrees to Acquire Exclusive U.S. Commercial Rights to Eylea® Biosimilar FYB203 from Klinge Biopharma
- Coherus BioSciences Management to Present at the 41st Annual J.P. Morgan Healthcare Conference
- Coherus BioSciences (NASDAQ:CHRS) Stock Falls on FDA Delay